Diana Kwong, MD, MAS

Assistant Instructor

Dr. Diana Kwong is board-certified nephrologist and practices both inpatient and outpatient kidney medicine. She specializes in treating patients with acute kidney injury, chronic kidney disease, end-stage kidney disease, hypertension, electrolyte imbalances and glomerular disorders. She is also a clinical researcher focused on improving clinical care and understanding patient reported outcomes after acute kidney injury. She is a member of the American Society of Nephrology and National Kidney Foundation.

Education
Residency, - Internal Medicine, Johns Hopkins Hospital
MD, - Medicine, Johns Hopkins Hospital
BA, - Public Health Studies; History of Science and Technology, Johns Hopkins University
MAS, - Clinical Research, UCSF
- Diversity, Equity, and Inclusion Champion Training, UCSF
Fellowship, - Nephrology, UCSF
Publications

  1. Kwong YD, Liu KD. Impact of Adsorptive Blood Purification on Kidney Outcomes. JAMA 2024. PMID: 39382233


  2. Kwong YD, Hsu RK. Antivirals in Herpes Zoster and AKI: Old Foes, New Insights. Clinical journal of the American Society of Nephrology : CJASN 2024. PMID: 38758601


  3. Neyra JA, Gewin L, Ng JH, Barreto EF, Freshly B, Willett J, Abdel-Rahman EM, McCoy I, Kwong YD, Silver SA, Cerda J, Vijayan A. Challenges in the Care of Patients with AKI Receiving Outpatient Dialysis: AKINow Recovery Workgroup Report. Kidney360 2023. PMID: 38055734


  4. Barreto EF, Cerda J, Freshly B, Gewin L, Kwong YD, McCoy IE, Neyra JA, Ng JH, Silver SA, Vijayan A, Abdel-Rahman EM. Optimum Care of AKI Survivors Not Requiring Dialysis after Discharge: An AKINow Recovery Workgroup Report. Kidney360 2023. PMID: 37986185


  5. Kwong YD, Liu KD, Hsu CY, Cooper B, Palevsky PM, Kellum JA, Johansen KL, Miaskowski C. Subgroups of patients with distinct health utility profiles following acute kidney injury. Kidney360 2023. PMID: 37357351


  6. Kwong YD, Hsu CY. In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y. Annals of internal medicine 2023. PMID: 36877974


  7. Kwong YD, Tuot DS. Optimizing Self-Management Programs in Kidney Disease: Implementation of Sick-Day Protocols. Kidney Medicine 2022. PMID: 36071743


  8. Kwong YD, Liu KD, Hsu RK. Kidney Dysfunction After Acute Heart Failure: Is Acute Kidney Disease the New Acute Kidney Injury? 2021. PMID: 35257051


  9. Kwong YD, Liu KD, Lo LJ. Outpatient Dietary Management of Electrolyte Disorders During COVID-19: Food as Medicine. JAMA internal medicine 2021. PMID: 33555305


  10. McAllister S, Lai JC, Copeland TP, Johansen KL, McCulloch CE, Kwong YD, Seth D, Grimes B, Ku E. Renal Recovery and Mortality Risk among Patients with Hepatorenal Syndrome Receiving Chronic Maintenance Dialysis. 2021. PMID: 35373067


  11. Kwong YD, Mehta K, Miaskowski C, Zhuo H, Yee K, Jauregui A, Ke S, Deiss T, Abbott J, Kangelaris KN, Sinha P, Hendrickson CM, Gomez A, Leligdowicz A, Matthay MA, Calfee CS, Liu KD. Using Best Subsets Regression to Identify Clinical Characteristics and Biomarkers Associated with Sepsis-Associated Acute Kidney Injury. American journal of physiology. Renal physiology 2020. PMID: 33044866


  12. Kwong YD, Liu KD, Hsu RK, Johansen KL, McCulloch CE, Seth D, Fallahzadeh MK, Grimes BA, Ku E. Recovery of Kidney Function Among Patients With Glomerular Disease Starting Maintenance Dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation 2020. PMID: 32771649


  13. Hendrickson CM, Kwong YD, Belzer AG, Shlipak MG, Matthay MA, Liu KD. Higher plasma cystatin C is associated with mortality after acute respiratory distress syndrome: findings from a Fluid and Catheter Treatment Trial (FACTT) substudy. Critical care (London, England) 2020. PMID: 32653023


  14. Kwong YD, Chen S, Bouajram R, Li F, Matthay MA, Mehta KM, Glidden DV, Liu KD. The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury. PloS one 2019. PMID: 31770424


  15. Kwong YD, Liu KD. Prediction Models for AKI: Will They Result in Improved Outcomes for AKI? Clinical journal of the American Society of Nephrology : CJASN 2019. PMID: 30917995


  16. Kwong YD, Liu KD. Selection of Intravenous Fluids. American journal of kidney diseases : the official journal of the National Kidney Foundation 2018. PMID: 29980374


  17. Jung M, Warren B, Grams M, Kwong YD, Shafi T, Coresh J, Rebholz CM, Selvin E. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study. Volume 10 of Issue 4. Journal of diabetes 2017. PMID: 29055090


  18. Kwong YD, Liu KD. AKI Adjudication: Do We Need It. Nephron 2017. PMID: 28614829


  19. Gilani Z, Kwong YD, Levine OS, Deloria-Knoll M, Scott JA, O'Brien KL, Feikin DR. A literature review and survey of childhood pneumonia etiology studies: 2000-2010. Volume 54 Suppl 2. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012. PMID: 22403223


  20. Kwong YT, Knoepp LR, Wright EJ, Chen CC. Recurrent pelvic organ prolapse in a patient with history of bladder exstrophy. Volume 18 of Issue 1. Female pelvic medicine & reconstructive surgery 2012. PMID: 22453272


  21. Kwong YT, Stevens LA, Selvin E, Zhang YL, Greene T, Van Lente F, Levey AS, Coresh J. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Volume 56 of Issue 1. American journal of kidney diseases : the official journal of the National Kidney Foundation 2010. PMID: 20537455


  22. Hallan SI, Kwong D, Vikse BE, Stevens P. Use of a prostate symptom score to identify men at risk of future kidney failure: insights from the HUNT II Study. Volume 56 of Issue 3. American journal of kidney diseases : the official journal of the National Kidney Foundation 2010. PMID: 20541300